JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,153,000 | -29.7% | 492,556 | -9.0% | 0.01% | -25.0% |
| Q2 2022 | $1,640,000 | -54.4% | 541,127 | +2.1% | 0.02% | -48.4% |
| Q1 2022 | $3,597,000 | +13.0% | 529,823 | +39.0% | 0.03% | +29.2% |
| Q4 2021 | $3,182,000 | +12.4% | 381,046 | +0.0% | 0.02% | +9.1% |
| Q3 2021 | $2,830,000 | +16.1% | 380,934 | +6.3% | 0.02% | +10.0% |
| Q2 2021 | $2,437,000 | +131.0% | 358,399 | +248.7% | 0.02% | +100.0% |
| Q1 2021 | $1,055,000 | +63.3% | 102,770 | +11.3% | 0.01% | +66.7% |
| Q4 2020 | $646,000 | -15.4% | 92,350 | -1.4% | 0.01% | -25.0% |
| Q3 2020 | $764,000 | +18.3% | 93,630 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $646,000 | +47.2% | 93,630 | +1.3% | 0.01% | +14.3% |
| Q1 2020 | $439,000 | – | 92,470 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |